nach oben

Erschienen in:

01.06.2015 | General Gynecology

The early-onset preeclampsia is associated with MTHFR and FVL polymorphisms

verfasst von: Saeedeh Salimi, Mohsen Saravani, Minoo Yaghmaei, Zeinab Fazlali, Mojgan Mokhtari, Anoosh Naghavi, Farzaneh Farajian-Mashhadi

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to examine the association of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase (MTHFR) polymorphisms and preeclampsia (PE) in Southeast of Iran.

Methods

This case–control study was performed on 192 preeclamptic and 196 normotensive pregnant women. Single nucleotide polymorphisms were genotyped using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) and Tetra ARMS methods.

Results

No significant differences were observed in distribution of MTHFR C677T and FVL polymorphisms between two groups. There was a significant difference in frequency of 1298AC genotype in PE pregnant women compared to controls (P = 0.03). No 20210A allele of prothrombin gene was observed in this population. The analysis of MTHFR and factor V Leiden polymorphisms between early-onset PE (EOPE) and late-onset PE (LOPE) showed significant differences in MTHFR A1298C polymorphism (AC and CC vs AA, P = 0.012 and P = 0.006, respectively) and G1691A polymorphism of FVL(GA vs GG, P = 0.03). Moreover, the analysis of three SNPs between EOPE and controls showed significant differences in MTHFR C677T (CT + TT vs CC, P = 0.035) and MTHFR A1298C (AC and CC vs AA, P = 0.001 and P = 0.006, respectively) polymorphisms. The synergic effect of MTHFR A1298C and C677T polymorphisms showed increased risk of EOPE.

Conclusion

MTHFR A1298C polymorphism was associated with PE. Although MTHFR C677T and FVL polymorphisms did not differ between PE patients and controls, significant differences in MTHFR A1298C, C677T and FVL polymorphisms between EOPE and LOPE/controls were observed. The synergic effect of MTHFR variants could increase PE and EOPE risk.

Broughton Pipkin F (1995) The hypertensive disorders of pregnancy. BMJ 311(7005):609–613CrossRefPubMedCentralPubMed

Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365(9461):785–799. doi:10.1016/S0140-6736(05)17987-2 CrossRefPubMed

Powe CE, Levine RJ, Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123(24):2856–2869. doi:10.1161/CIRCULATIONAHA.109.853127 CrossRefPubMed

Roberts JM, Hubel CA (2009) The two stage model of preeclampsia: variations on the theme. Placenta 30(Suppl A):S32–S37. doi:10.1016/j.placenta.2008.11.009 CrossRefPubMedCentralPubMed

von Dadelszen P, Magee LA, Roberts JM (2003) Subclassification of preeclampsia. Hypertens Pregnancy Off J Int Soc Study Hypertens Pregnancy 22(2):143–148. doi:10.1081/PRG-120021060 CrossRef

von Dadelszen P, Magee LA, Lee SK, Stewart SD, Simone C, Koren G, Walley KR, Russell JA (2002) Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med 30(8):1883–1892CrossRef

Williams PJ, Broughton Pipkin F (2011) The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 25(4):405–417. doi:10.1016/j.bpobgyn.2011.02.007 CrossRefPubMedCentralPubMed

Mutze S, Rudnik-Schoneborn S, Zerres K, Rath W (2008) Genes and the preeclampsia syndrome. J Perinat Med 36(1):38–58. doi:10.1515/JPM.2008.004 CrossRefPubMed

Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA, Thrombosis R, Economic Assessment of Thrombophilia Screening S (2006) Thrombophilia in pregnancy: a systematic review. Br J Haematol 132(2):171–196. doi:10.1111/j.1365-2141.2005.05847.x CrossRef

10.

Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL, Mackman N, Weiler H (2003) The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med 9(3):331–337. doi:10.1038/nm825 CrossRefPubMed

11.

Brenner B (2002) Thrombophilia and pregnancy loss. Thromb Res 108(4):197–202CrossRefPubMed

12.

Also-Rallo E, Lopez-Quesada E, Urreizti R, Vilaseca MA, Lailla JM, Balcells S, Grinberg D (2005) Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol 120(1):45–52. doi:10.1016/j.ejogrb.2004.08.008 CrossRefPubMed

13.

Dalmaz CA, Santos KG, Botton MR, Tedoldi CL, Roisenberg I (2006) Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population. Blood Cells Mol Dis 37(2):107–110. doi:10.1016/j.bcmd.2006.07.005 CrossRefPubMed

14.

De Maat MP, Jansen MW, Hille ET, Vos HL, Bloemenkamp KW, Buitendijk S, Helmerhorst FM, Wladimiroff JW, Bertina RM, De Groot CJ (2004) Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost JTH 2(9):1588–1593. doi:10.1111/j.1538-7836.2004.00861.x CrossRef

15.

Dissanayake VH, Sirisena ND, Weerasekera LY, Gammulla CG, Seneviratne HR, Jayasekara RW (2012) Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women. J Obstet Gynaecol Res 38(9):1168–1176. doi:10.1111/j.1447-0756.2012.01846.x CrossRefPubMed

16.

Yamada K, Chen Z, Rozen R, Matthews RG (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98(26):14853–14858. doi:10.1073/pnas.261469998 CrossRefPubMedCentralPubMed

17.

Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113. doi:10.1038/ng0595-111 CrossRefPubMed

18.

Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64(3):169–172. doi:10.1006/mgme.1998.2714 CrossRefPubMed

19.

Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93(1):7–9CrossRefPubMed

20.

Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlback B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U (1996) Inherited thrombophilia: Part 1. Thromb Haemost 76(5):651–662PubMed

21.

van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA (1996) Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 75(3):417–421PubMed

22.

Endler G, Mannhalter C (2003) Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clinica chimica acta Int J Clin Chem 330(1–2):31–55CrossRef

23.

Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703PubMed

24.

Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G (1997) Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77(6):1052–1054PubMed

25.

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000). Am J Obstet Gynecol 183 (1):S1–S22

26.

Valensise H, Vasapollo B, Gagliardi G, Novelli GP (2008) Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52(5):873–880. doi:10.1161/HYPERTENSIONAHA.108.117358 CrossRefPubMed

27.

Grunebaum L, Cazenave JP, Camerino G, Kloepfer C, Mandel JL, Tolstoshev P, Jaye M, De la Salle H, Lecocq JP (1984) Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation factor IX gene. J Clin Investig 73(5):1491–1495. doi:10.1172/JCI111354 CrossRefPubMedCentralPubMed

28.

Michael S, Qamar R, Akhtar F, Khan WA, Ahmed A (2008) C677T polymorphism in the methylenetetrahydrofolate reductase gene is associated with primary closed angle glaucoma. Mol Vis 14:661–665PubMedCentralPubMed

29.

Han IB, Kim OJ, Ahn JY, Oh D, Hong SP, Huh R, Chung SS, Kim NK (2010) Association of methylenetetrahydrofolate reductase (MTHFR 677C > T and 1298A > C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population. Yonsei Med J 51(2):253–260. doi:10.3349/ymj.2010.51.2.253 CrossRefPubMedCentralPubMed

30.

Gaunt TRRS, Day IN (2007) Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool ‘CubeX’. BMC Bioinformatics 8:428CrossRefPubMedCentralPubMed

31.

Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143(10):697–706CrossRefPubMed

32.

Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 342(6):374–380. doi:10.1056/NEJM200002103420602 CrossRefPubMed

33.

Cotter AM, Molloy AM, Scott JM, Daly SF (2001) Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 185(4):781–785. doi:10.1067/mob.2001.117304 CrossRefPubMed

34.

Murphy RP, Donoghue C, Nallen RJ, D’Mello M, Regan C, Whitehead AS, Fitzgerald DJ (2000) Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 20(1):266–270CrossRefPubMed

35.

Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T (1997) Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 34(6):525–526CrossRefPubMedCentralPubMed

36.

Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Roberts JM (1999) Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig 6(2):74–79CrossRefPubMed

37.

Kaiser T, Brennecke SP, Moses EK (2001) C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women. Human Hered 51 (1–2):20–22. doi:22954

38.

Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L (1999) 5,10 methylenetetrahydrofolate reductase polymorphism in black South African women with pre-eclampsia. Br J Obstet Gynaecol 106(11):1219–1220CrossRefPubMed

39.

Rajkovic A, Mahomed K, Rozen R, Malinow MR, King IB, Williams MA (2000) Methylenetetrahydrofolate reductase 677 C → T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metab 69(1):33–39. doi:10.1006/mgme.1999.2952 CrossRefPubMed

40.

Coral-Vazquez RM, Romero Arauz JF, Canizales-Quinteros S, Coronel A, Valencia Villalvazo EY, Hernandez Rivera J, Ramirez Regalado B, Rojano Mejia D, Canto P (2013) Analysis of polymorphisms and haplotypes in genes associated with vascular tone, hypertension and oxidative stress in Mexican-Mestizo women with severe preeclampsia. Clin Biochem 46(7–8):627–632. doi:10.1016/j.clinbiochem.2012.12.016 CrossRefPubMed

41.

O’Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH (1999) Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 33(6):1338–1341CrossRefPubMed

42.

Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K (2000) 677 C → T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 96(2):277–280CrossRefPubMed

43.

Rigo J Jr, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, Papp Z (2000) Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy Off J Int Soc Study Hypertens Pregnancy 19(2):163–172CrossRef

44.

D’Elia AV, Driul L, Giacomello R, Colaone R, Fabbro D, Di Leonardo C, Florio P, Petraglia F, Marchesoni D, Damante G (2002) Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Invest 53 (2):84–87. doi:52998

45.

Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA (2002) Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 87(5):779–785PubMed

46.

Davalos IP, Moran MC, Martinez-Abundis E, Gonzalez-Ortiz M, Flores-Martinez SE, Machorro V, Sandoval L, Figuera LE, Mena JP, Oliva JM, Tlacuilo-Parra JA, Sanchez-Corona J, Salazar-Paramo M (2005) Methylenetetrahydrofolate reductase C677T polymorphism and factor V Leiden variant in Mexican women with preeclampsia/eclampsia. Blood Cells Mol Dis 35(1):66–69. doi:10.1016/j.bcmd.2005.03.008 CrossRefPubMed

47.

Prasmusinto D, Skrablin S, Fimmers R, van der Ven K (2004) Ethnic differences in the association of factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with preeclampsia. Eur J Obstet Gynecol Reprod Biol 112(2):162–169CrossRefPubMed

48.

Dusse LM, Carvalho M, Braganca WF, Paiva SG, Godoi LC, Guimaraes DA, Fernandes AP (2007) Inherited thrombophilias and pre-eclampsia in Brazilian women. Eur J Obstet Gynecol Reprod Biol 134(1):20–23. doi:10.1016/j.ejogrb.2006.09.006 CrossRefPubMed

49.

Lin J, August P (2005) Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105(1):182–192. doi:10.1097/01.AOG.0000146250.85561.e9 CrossRefPubMed

50.

Canto P, Canto-Cetina T, Juarez-Velazquez R, Rosas-Vargas H, Rangel-Villalobos H, Canizales-Quinteros S, Velazquez-Wong AC, Villarreal-Molina MT, Fernandez G, Coral-Vazquez R (2008) Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women. Hypertens Res Off J Jpn Soc Hypertens 31(5):1015–1019. doi:10.1291/hypres.31.1015 CrossRef

51.

Aggarwal S, Dimri N, Tandon I, Agarwal S (2011) Preeclampsia in North Indian women: the contribution of genetic polymorphisms. J Obstet Gynaecol Res 37(10):1335–1341. doi:10.1111/j.1447-0756.2010.01523.x CrossRefPubMed

52.

Wang XM, Wu HY, Qiu XJ (2013) Methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and risk of preeclampsia: an updated meta-analysis based on 51 studies. Arch Med Res 44(3):159–168. doi:10.1016/j.arcmed.2013.01.011 CrossRefPubMed

53.

Xia XP, Chang WW, Cao YX (2012) Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia. Hypertens Res Off J Jpn Soc Hypertens 35(12):1129–1134. doi:10.1038/hr.2012.117 CrossRef

54.

Kaiser T, Brennecke SP, Moses EK (2000) Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women. Gynecologic and obstetric investigation 50 (2):100–102. doi:10291

55.

Pegoraro RJ, Chikosi A, Rom L, Roberts C, Moodley J (2004) Methylenetetrahydrofolate reductase gene polymorphisms in black South Africans and the association with preeclampsia. Acta Obstet Gynecol Scand 83(5):449–454. doi:10.1111/j.0001-6349.2004.0355.x CrossRefPubMed

56.

Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE (2006) Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM Mon J Assoc Physician 99(5):289–298. doi:10.1093/qjmed/hcl040 CrossRef

57.

Malek-Khosravi S, Rahimi Z, Rahimi Z, Jalilvand F, Parsian A (2012) Thrombophilic mutations and susceptibility to preeclampsia in Western Iran. J Thromb Thrombolysis 33(1):109–115. doi:10.1007/s11239-011-0653-y CrossRefPubMed

58.

Rahimi Z, Malek-Khosravi S, Rahimi Z, Jalilvand F, Parsian A (2013) MTHFR C677T and eNOS G894T variants in preeclamptic women: contribution to lipid peroxidation and oxidative stress. Clin Biochem 46(1–2):143–147. doi:10.1016/j.clinbiochem.2012.10.020 CrossRefPubMed

Titel: The early-onset preeclampsia is associated with MTHFR and FVL polymorphisms
verfasst von: Saeedeh Salimi
Mohsen Saravani
Minoo Yaghmaei
Zeinab Fazlali
Mojgan Mokhtari
Anoosh Naghavi
Farzaneh Farajian-Mashhadi
Publikationsdatum: 01.06.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-014-3561-5

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

The early-onset preeclampsia is associated with MTHFR and FVL polymorphisms

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2015

Antiphospholipid syndrome and other autoimmune diseases associated with chronic intervillositis

Legal liability in South Korea

Systematic assessment of surgical complications in 438 cases of vaginal native tissue repair for pelvic organ prolapse adopting Clavien–Dindo classification

Questions about and speculations on the incidence of idiopathic polyhydramnios by fetal gender

Total laparoscopic hysterectomy, vaginal hysterectomy and total abdominal hysterectomy using electrosurgical bipolar vessel sealing technique: a randomized controlled trial

Relationship between preeclampsia and vitamin D deficiency: a case control study

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie